A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.
- DOI
- 10.3390/cancers18142362
- Published
- 2026 Jul 22
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18142362,
title = {A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.},
author = {Pluard T and Grinda T and Dienstmann R and Thill M and Korytowsky B and Chen C and Portuhay S and Salvo-Halloran EM and Samjoo IA and Harbeck N},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18142362},
url = {https://doi.org/10.3390/cancers18142362}
}RIS
TY - JOUR TI - A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence. AU - Pluard T AU - Grinda T AU - Dienstmann R AU - Thill M AU - Korytowsky B AU - Chen C AU - Portuhay S AU - Salvo-Halloran EM AU - Samjoo IA AU - Harbeck N PY - 2026 JO - Cancers DO - 10.3390/cancers18142362 UR - https://doi.org/10.3390/cancers18142362 ER -
APA
T, P., T, G., R, D., M, T., B, K., C, C., S, P., EM, S., IA, S., & N, H. (2026). A Systematic Literature Review of the Effectiveness of CDK 4/6 Inhibitors for First-Line Treatment of HR+/HER2- Advanced/Metastatic Breast Cancer: A Comparison of Real-World Evidence.. Cancers. https://doi.org/10.3390/cancers18142362
Source records
- pubmed · retrieved 2026-09-25T22:17:57.849Z
- europe-pmc · retrieved 2026-09-25T22:17:57.877Z